High materiality7/10
Oscar Health price target raised to $49 from $39 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises OSCR price target to $49 from $39; current price around $32.34.
- Target $49
- Current price $32.34
- Analyst firm Barclays
- Analyst Andrew Mok
Key facts
- 01
Target: $49
- 02
Posted price: $32.34
- 03
Analyst firm: Barclays
- 04
Analyst: Andrew Mok
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.